Research Article
The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
Figure 5
dBET57 exhibits tumor growth inhibition effect in xenograft tumor model. (a) Flow chart of the xenograft tumor model. (b) Body weight curve of nude mice surviving 21 days. (c) Tumor signal values in nude mice. (d) Measurement of tumor size in control and experimental groups. (e) Statistics of the average weight of the two groups of tumors. (f) Tumor growth curves of experimental group and control group. (g) Immunohistochemistry of BRD4, Ki67, and Caspase3. Scale bars: 100 μm. (h) Pathological sections of the kidney, liver, spleen, and lung. Scale bars: 100 μm. The experimental group (intraperitoneal injection of dBET57) was compared with the control group. , , ; ns: not significant.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |